STAGE IIIA BLADDER CANCER AJCC V8
Clinical trials for STAGE IIIA BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer breakthrough? trial tests cutting treatment time by 75%
Disease control Recruiting nowThis large Phase 3 trial is testing whether a much shorter, more intense course of radiation (5 sessions) works as well as the standard longer course (20 sessions) for patients with muscle-invasive bladder cancer. All participants will also receive standard chemotherapy. The main…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New 'Smart Bomb' drug aims to shrink tough bladder tumors before surgery
Disease control Recruiting nowThis study is testing if a targeted drug called sacituzumab govitecan can help shrink tumors before surgery for patients with a rare and aggressive type of bladder cancer. The drug acts like a 'smart bomb,' attaching to cancer cells to deliver chemotherapy directly to them. The g…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Bladder-Saving combo could spare cancer patients major surgery
Disease control Recruiting nowThis study is testing whether a combination of radiation therapy and an immunotherapy drug (pembrolizumab) can help patients with muscle-invasive bladder cancer avoid having their bladder surgically removed. It is for patients whose tumors have shrunk significantly after initial …
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo tested for tough bladder cancers
Disease control Recruiting nowThis study is testing a combination of two drugs, futibatinib and durvalumab, given before surgery to remove the bladder. It is for patients with muscle-invasive bladder cancer who cannot receive the usual chemotherapy due to other health problems like kidney issues or heart fail…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo aims to fight bladder cancer without removing the bladder
Disease control Recruiting nowThis study is testing a new combination of two cancer drugs (enfortumab vedotin and pembrolizumab) given alongside targeted radiation therapy. The goal is to see if this approach can effectively control muscle-invasive bladder cancer for patients who are not candidates for, or wh…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Major study tracks how bladder cancer survivors really feel
Knowledge-focused Recruiting nowThis study aims to understand how different treatments for early-stage bladder cancer affect patients' quality of life over time. Researchers will follow 704 survivors for three years, asking them to complete surveys about their physical, emotional, and social well-being. The goa…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC